Patents by Inventor Stéphanie Philippe

Stéphanie Philippe has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10308955
    Abstract: The present invention describes a recombinant retroviral vector which cannot by itself achieve complete reverse transcription as well as its uses, in particular for transiently transferring in vitro, ex vivo or in vivo at least one ribonucleic acid sequence of interest in a cell. Such a transient transgene expression is of interest in the context of research, therapy and more generally in the field of biotechnology.
    Type: Grant
    Filed: October 26, 2012
    Date of Patent: June 4, 2019
    Assignee: NEWVECTYS
    Inventors: Chamsy Sarkis, Dorothee Altemir, Nicolas Grandchamp, Stephanie Philippe
  • Publication number: 20140286907
    Abstract: The present invention describes a recombinant retroviral vector which cannot by itself achieve complete reverse transcription as well as its uses, in particular for transiently transferring in vitro, ex vivo or in vivo at least one ribonucleic acid sequence of interest in a cell. Such a transient transgene expression is of interest in the context of research, therapy and more generally in the field of biotechnology.
    Type: Application
    Filed: October 26, 2012
    Publication date: September 25, 2014
    Inventors: Chamsy Sarkis, Dorothee Altemir, Nicolas Grandchamp, Stephanie Philippe
  • Patent number: 8119119
    Abstract: The invention concerns a non-integrative and non-replicative recombinant lentivirus as well as its uses, in particular for preparing a composition for transferring genes in vitro, ex vivo or in vivo. The invention is useful for transferring genes in any mammal organism, for example in liver, muscle, pancreas or central nervous system (including the ocular sphere) tissues or cells, and in particular for treating disorders or pathologies such as, for example, central nervous system, including the ocular sphere, disorders.
    Type: Grant
    Filed: June 24, 2005
    Date of Patent: February 21, 2012
    Assignee: Centre National de la Recherche Scientifique
    Inventors: Jacques Mallet, Che Serguera, Stéphanie Philippe, Chamsy Sarkis
  • Publication number: 20080089863
    Abstract: The invention concerns a non-integrative and non-replicative recombinant lentivirus as well as its uses, in particular for preparing a composition for transferring genes in vitro, ex vivo or in vivo. The invention is useful for transferring genes in any mammal organism, for example in liver, muscle, pancreas or central nervous system (including the ocular sphere) tissues or cells, and in particular for treating disorders or pathologies such as, for example, central nervous system, including the ocular sphere, disorders.
    Type: Application
    Filed: June 24, 2005
    Publication date: April 17, 2008
    Inventors: Jacques Mallet, Che Serguera, Stephanie Philippe